Search Results - "Gumuskaya, B"

  • Showing 1 - 15 results of 15
Refine Results
  1. 1

    Assessing the order of critical alterations in prostate cancer development and progression by IHC: further evidence that PTEN loss occurs subsequent to ERG gene fusion by Gumuskaya, B, Gurel, B, Fedor, H, Tan, H-L, Weier, C A, Hicks, J L, Haffner, M C, Lotan, T L, De Marzo, A M

    Published in Prostate cancer and prostatic diseases (01-06-2013)
    “…Background: ERG rearrangements and PTEN (phosphatase and tensin homolog deleted on chromosome 10) loss are two of the most common genetic alterations in…”
    Get full text
    Journal Article
  2. 2

    A Rare Cause of Nasal Obstruction: Metastatic Renal Cell Carcinoma by Kokenek-Unal, Tuba Dilay, Gumuskaya, B., Ocal, B., Alper, Murat

    Published in Case reports in pathology (01-01-2016)
    “…Introduction. Renal cell carcinoma can present with several interesting symptoms, paraneoplastic syndromes, and unusual metastatic sites. Head and neck region…”
    Get full text
    Journal Article
  3. 3

    ERCC1 expression in triple negative breast cancer by Ozkan, C, Gumuskaya, B, Yaman, S, Aksoy, S, Guler, G, Altundag, K

    Published in Journal of B.U. ON. (01-04-2012)
    “…Excision repair cross-complementation group 1 (ERCC1), which is a component of nucleotide excision repair (NER) pathway, removes platinum-induced DNA adducts…”
    Get more information
    Journal Article
  4. 4

    Evaluation of changes of biologic markers ER, PR, HER 2 and Ki-67 in breast cancer with administration of neoadjuvant dose-dense doxorubicin, cyclophosphamide followed by paclitaxel by Dede, D S, Gumuskaya, B, Guler, G, Onat, D, Altundag, K, Ozisik, Y

    Published in Journal of B.U. ON. (01-01-2013)
    “…To assess the changes of biologic markers estrogen receptors (ER), progesterone receptors (PR), HER 2 and Ki-67 in locally advanced breast cancer patients…”
    Get more information
    Journal Article
  5. 5
  6. 6
  7. 7
  8. 8
  9. 9
  10. 10
  11. 11

    Evaluation of changes in biologic markers ER, PR, HER 2 and Ki-67 index in breast cancer with administration of neoadjuvant dose dense doxorubicin, cyclophosphamide followed by paclitaxel chemotherapy by Dede, D S, Gumuskaya, B, Guler, G, Onat, D, Altundag, K, Ozisik, Y

    Published in Journal of B.U. ON. (01-04-2013)
    “…The aim of this study was to assess the changes in biologic markers of breast cancer ER, PR, HER 2 and Ki-67 in locally advanced breast cancer patients after…”
    Get more information
    Journal Article
  12. 12
  13. 13
  14. 14
  15. 15